Zepp Health (ZEPP) Cash & Equivalents (2016 - 2026)

Zepp Health has reported Cash & Equivalents for 11 years, with the latest figure at $69.7 million in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 25.64% year-over-year to $69.7 million in Q2 2026; TTM through Jun 2026 was $69.7 million, a 25.64% increase from a year earlier, with the FY2025 full-year figure at $57.0 million, down 37.36% from the prior year.
• Cash & Equivalents was $69.7 million for Q2 2026 at Zepp Health, up from $52.4 million in the prior quarter.
• The five-year high for Cash & Equivalents was $161.2 million in Q1 2022, with the low at $52.4 million in Q1 2026.
• Average Cash & Equivalents over 5 years is $106.6 million, with a median of $121.3 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Cash & Equivalents tumbled 53.25% in 2025, then rose 25.64% in 2026.
• Over 5 years, Cash & Equivalents stood at $124.7 million in 2022, then rose by 5.73% to $131.8 million in 2023, then tumbled by 30.91% to $91.1 million in 2024, then sank by 37.36% to $57.0 million in 2025, then climbed by 22.11% to $69.7 million in 2026.
• The last three Cash & Equivalents figures came in at $69.7 million (Q2 2026), $52.4 million (Q1 2026), and $57.0 million (Q4 2025), per Business Quant data.